Skip to content

HBIO

HARVARD BIOSCIENCE INC

NASDAQ · Healthcare · Medical - Instruments & Supplies · US

$7.95
−1.00%
Ask drillr
Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open
$8.10
From 52W high
−3.05%
Volume
19220.00
Market cap
$36.19M
P/E (Fwd)
44.2x
EV/EBITDA
−78.7x
P/E (TTM)
RSI (14)
66.1
1D Return
−1.00%
YTD Return
+21.00%
SummaryUpdated Jun 1, 2026

Harvard Bioscience, Inc. (NASDAQ:HBIO) is a Massachusetts-based company founded in 1901 that develops, manufactures, and sells specialized scientific instruments and technologies for life sciences research. Originally established as Harvard Apparatus, the company has evolved over more than a century from a small scientific instrument maker into a publicly traded corporation serving the global research community. Today, Harvard Bioscience operates as a niche player in the scientific instrumentation market, providing essential tools that enable fundamental research, drug discovery, and preclinical testing across pharmaceutical companies, biotechnology firms, universities, and government laboratories worldwide.

Similar companies

Latest newsMore news →